calcium dobesilate has been researched along with Diabetes Mellitus in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 6 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Y; Liu, C; Yu, M | 1 |
| Ashraful-Haque, SZ; Che, JJ; Chen, KY; Guo, SH; Li, GP; Liu, T; Rha, SW; Tao, HY; Wang, JR; Xue, ZK; Zhang, H; Zhang, YR | 1 |
| An, X; Duan, L; Duan, Y; Kang, X; Lian, F; Zhang, Y; Zhou, R | 1 |
| Wang, D; Wang, H; Wu, S; Xu, J; Yang, X | 1 |
| Hu, H; Liu, J; Qiu, S; Song, Q; Sun, ZL; Wang, D; Wang, F; Wen, L; Yuan, Y | 1 |
| Akbari, M; Ashraf, H; Ghaffari, M; Jahanbani-Ardakani, H; Khalili, MR; Lotfi, M | 1 |
| Mou, S; Ni, Z; Qi, C; Shao, X; Yuan, J; Zhou, Y | 1 |
| Allona, A; Angulo, J; Cuevas, P; Fernández, A; Gabancho, S; Martín-Morales, A; Moncada, I; Sáenz de Tejada, I; Videla, S | 1 |
| Beyer, J; Cordes, U; Happ, J; Meissner, KO | 1 |
| Beyer, J | 1 |
| Berger, M; Jörgens, V | 1 |
2 review(s) available for calcium dobesilate and Diabetes Mellitus
| Article | Year |
|---|---|
Effect of Chinese Patent Medicines on Ocular Fundus Signs and Vision in Calcium Dobesilate-Treated Persons With Non-Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
Topics: Calcium Dobesilate; China; Diabetes Mellitus; Diabetic Retinopathy; Drugs, Chinese Herbal; Humans; Nonprescription Drugs | 2022 |
Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study.
Topics: Angiogenesis Inhibitors; Calcium Dobesilate; Case-Control Studies; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Observational Studies as Topic; Ranibizumab; Retrospective Studies; Treatment Outcome | 2022 |
1 trial(s) available for calcium dobesilate and Diabetes Mellitus
| Article | Year |
|---|---|
Efficacy of calcium dobesilate in treating Chinese patients with mild-to-moderate non-proliferative diabetic retinopathy (CALM-DR): protocol for a single-blind, multicentre, 24-armed cluster-randomised, controlled trial.
Topics: Calcium Dobesilate; China; Diabetes Mellitus; Diabetic Retinopathy; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retinal Vessels; Single-Blind Method | 2021 |
8 other study(ies) available for calcium dobesilate and Diabetes Mellitus
| Article | Year |
|---|---|
Effects of calcium dobesilate combined with categlicine and valsartan capsules on inflammation and cellular immunity in patients with diabetic nephropathy.
Topics: Calcium Dobesilate; Capsules; Diabetes Mellitus; Diabetic Nephropathies; Humans; Immunity, Cellular; Inflammation; Valsartan | 2023 |
Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease.
Topics: Biomarkers; Calcium Dobesilate; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Glomerular Filtration Rate; Humans; Kidney Diseases; Percutaneous Coronary Intervention; Renal Insufficiency, Chronic | 2021 |
Effect of calcium dobesilate on retrobulbar blood flow and choroidal thickness in patients with non-proliferative diabetic retinopathy.
Topics: Adult; Aged; Blood Flow Velocity; Calcium Dobesilate; Ciliary Arteries; Diabetes Mellitus; Diabetic Retinopathy; Humans; Middle Aged; Ophthalmic Artery; Regional Blood Flow; Retinal Artery; Ultrasonography, Doppler, Color | 2021 |
Calcium dobesilate may alleviate diabetes‑induced endothelial dysfunction and inflammation.
Topics: Biomarkers; C-Reactive Protein; Calcium Dobesilate; Cell Membrane Permeability; Cell Movement; Cell Proliferation; Chemokine CCL2; Diabetes Mellitus; Endothelium, Vascular; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Neoplasm Proteins; Proteoglycans; RNA, Messenger; Serum Amyloid P-Component; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF.
Topics: Acetylcholine; Arteries; Biological Factors; Calcium Dobesilate; Diabetes Complications; Diabetes Mellitus; Dose-Response Relationship, Drug; Endothelium, Vascular; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Penis; Piperazines; Purines; Reference Values; Sildenafil Citrate; Stress, Mechanical; Sulfones | 2003 |
[Effect of calcium dobesilate on permeation of plasma proteins in diabetic patients].
Topics: Aged; Benzenesulfonates; Beta-Globulins; Blood Proteins; Blood Sedimentation; Calcium Dobesilate; Capillary Permeability; Cholesterol; Diabetes Mellitus; Humans; Middle Aged; Platelet Aggregation; Serum Albumin; Triglycerides | 1980 |
Effects of permeation of plasma proteins in diabetic patients.
Topics: Benzenesulfonates; Blood Proteins; Blood Sedimentation; Calcium Dobesilate; Cholesterol; Diabetes Mellitus; Erythrocyte Count; Follow-Up Studies; Humans; Leukocyte Count; Middle Aged; Permeability; Platelet Aggregation; Triglycerides | 1981 |
[Calcium dobesilate for diabetes mellitus?].
Topics: Benzenesulfonates; Calcium Dobesilate; Diabetes Mellitus; Humans | 1981 |